Razo J - Search Results

1

The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions.

Harding FA, Stickler MM, Razo J, DuBridge RB. Harding FA, et al. Among authors: razo j. MAbs. 2010 May-Jun;2(3):256-65. doi: 10.4161/mabs.2.3.11641. Epub 2010 May 1. MAbs. 2010. PMID: 20400861 Free PMC article.

2

Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display and massively parallel pyrosequencing.

Forsyth CM, Juan V, Akamatsu Y, DuBridge RB, Doan M, Ivanov AV, Ma Z, Polakoff D, Razo J, Wilson K, Powers DB. Forsyth CM, et al. Among authors: razo j. MAbs. 2013 Jul-Aug;5(4):523-32. doi: 10.4161/mabs.24979. Epub 2013 May 29. MAbs. 2013. PMID: 23765106 Free PMC article.

3

Effects of repeated RU 24969 treatment on the locomotor activity, motoric capacity, and axillary temperatures of male and female preweanling rats.

McDougall SA, Razo JL, Rios JW, Taylor JA. McDougall SA, et al. Among authors: razo jl. Behav Brain Res. 2021 Feb 1;398:112982. doi: 10.1016/j.bbr.2020.112982. Epub 2020 Nov 6. Behav Brain Res. 2021. PMID: 33166571 Free article.

4

COVID-19 in South American Children: A Call For Action.

Antúnez-Montes OY, Escamilla MI, Figueroa-Uribe AF, Arteaga-Menchaca E, Lavariega-Sárachaga M, Salcedo-Lozada P, Sunohara RA, Melchior P, Del Razo JOF, Tirado-Caballero JC, Tasayco-Muñoz JA, Pinzon-Redondo H, Montes-Fontalvo LV, Ochoa T, Eduardo Campos F, Hernandez R, Limansky L, Del Aguila O, Buonsenso D. Antúnez-Montes OY, et al. Among authors: del razo jof. Pediatr Infect Dis J. 2020 Oct;39(10):e332-e334. doi: 10.1097/INF.0000000000002851. Pediatr Infect Dis J. 2020. PMID: 32826723 No abstract available.

5

Using Testing as a Learning Tool.

Yang BW, Razo J, Persky AM. Yang BW, et al. Among authors: razo j. Am J Pharm Educ. 2019 Nov;83(9):7324. doi: 10.5688/ajpe7324. Am J Pharm Educ. 2019. PMID: 31871352 Free PMC article. Review.

6

Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients.

Lucas AT, Robinson R, Schorzman AN, Piscitelli JA, Razo JF, Zamboni WC. Lucas AT, et al. Among authors: razo jf. Antibodies (Basel). 2019 Jan 1;8(1):3. doi: 10.3390/antib8010003. Antibodies (Basel). 2019. PMID: 31544809 Free PMC article. Review.

7

Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer.

Taylor SE, Petschauer JS, Donovan H, Schorzman A, Razo J, Zamboni WC, Edwards RP, Zorn KK. Taylor SE, et al. Among authors: razo j. Int J Gynecol Cancer. 2019 Jan;29(1):147-152. doi: 10.1136/ijgc-2018-000055. Int J Gynecol Cancer. 2019. PMID: 30640697 Clinical Trial.

8

Factors Affecting the Pharmacology of Antibody-Drug Conjugates.

Lucas AT, Price LSL, Schorzman AN, Storrie M, Piscitelli JA, Razo J, Zamboni WC. Lucas AT, et al. Among authors: razo j. Antibodies (Basel). 2018 Feb 7;7(1):10. doi: 10.3390/antib7010010. Antibodies (Basel). 2018. PMID: 31544862 Free PMC article. Review.

9

Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients.

Wang P, Mao Y, Razo J, Zhou X, Wong ST, Patel S, Elliott E, Shea E, Wu AH, Gaber AO. Wang P, et al. Among authors: razo j. Pharmacogenomics. 2010 Oct;11(10):1389-402. doi: 10.2217/pgs.10.105. Pharmacogenomics. 2010. PMID: 21047202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results